Johanne Weberpals

Johanne Weberpals

UNVERIFIED PROFILE

Are you Johanne Weberpals?   Register this Author

Register author
Johanne Weberpals

Johanne Weberpals

Publications by authors named "Johanne Weberpals"

Are you Johanne Weberpals?   Register this Author

18Publications

537Reads

30Profile Views

Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.

Mol Cancer Ther 2014 Nov 4;13(11):2559-71. Epub 2014 Sep 4.

Centre for Cancer Therapeutics, the Ottawa Hospital Research Institute, The University of Ottawa, Ottawa, Ontario, Canada. Faculty of Medicine and the Department of Biochemistry, The University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-1086DOI Listing
November 2014

Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection.

Int J Cancer 2012 Aug 11;131(3):E204-15. Epub 2012 Jan 11.

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27404DOI Listing
August 2012

Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer.

Cancer Genet 2011 Oct;204(10):525-35

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2011.09.004DOI Listing
October 2011

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells.

Cancer Cell Int 2011 Aug 19;11(1):29. Epub 2011 Aug 19.

Division of Gynaecologic Oncology, The Ottawa Hospital, 501 Smyth Road, Ottawa, K1H 8L6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2867-11-29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175148PMC
August 2011

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer.

J Oncol 2010 22;2010:891059. Epub 2010 Feb 22.

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/891059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825770PMC
July 2011

Comparative study of grade 3/4 toxicity associated with intraperitoneal chemotherapy administered after primary versus interval surgical debulking in ovarian cancer.

Int J Gynecol Cancer 2011 Jul;21(5):811-5

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e3182158640DOI Listing
July 2011

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.

Int J Cancer 2009 Feb;124(4):806-15

Division of Gynaecologic Oncology, The Ottawa Hospital, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23987DOI Listing
February 2009

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

J Clin Oncol 2008 Jul;26(19):3259-67

Ottawa Hospital, Division of Gynaecologic Oncology, Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.11.3902
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.11.3902DOI Listing
July 2008

A rare case of ectopic adrenocorticotropic hormone syndrome in small cell carcinoma of the vagina: a case report.

J Low Genit Tract Dis 2008 Apr;12(2):140-5

Division of Gynaecologic Oncology, The Ottawa Hospital, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0b013e31815cda1eDOI Listing
April 2008

Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia.

Gynecol Oncol 2007 Sep 19;106(3):579-84. Epub 2007 Jun 19.

Division of Gynecologic Oncology, Ottawa General Hospital, 501 Smyth Road-Room 8130, Ottawa, Ontario, Canada K1H 8L6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.05.019DOI Listing
September 2007